Literature DB >> 18188159

Hypertension control at physicians' offices in the United States.

Jing Fang1, Michael H Alderman, Nora L Keenan, Carma Ayala, Janet B Croft.   

Abstract

BACKGROUND: Uncontrolled hypertension is a common and important risk factor for heart disease and stroke. Nevertheless, the control rate among patients taking prescribed medication and/or therapeutic lifestyle modification has remained about the same for the past several decades.
METHODS: We analyzed 2003 and 2004 National Ambulatory Medical Care Survey (NAMCS) data to determine hypertension control in the physician offices in the United States. All visits for hypertension with measured blood pressure levels were included in the analyses. Survey weights were applied to obtain national estimates. Characteristics associated with hypertension control status were identified.
RESULTS: About 176 million hypertension-related office visits occurred (9.7% of total office visits) during 2003 and 2004. Of these, 17, 44, and 62% of visits had blood pressure <130/80 mm Hg, 140/90 mm Hg, and 145/95 mm Hg, respectively. The likelihood of hypertension control (<140/90 mm Hg) was associated with a diagnosis of coronary heart disease (odds ratio (OR) 1.54, 95% confidence interval (CI) = 1.01-2.35), visits with increased serum cholesterol (OR = 1.34, 95% CI = 1.09-1.65), visits with patients' primary care physician vs. those with non-primary care physicians (OR = 1.49, 95% CI = 1.05-2.10), and visits with internists (OR = 1.32, 95% CI = 1.05-1.67) or cardiologists (OR = 1.70, 95% CI = 1.17-2.471) vs. those with family physicians. Age, gender, race/ethnicity, health insurance status, and prescription of types of antihypertensive medicine were not associated with hypertension control in office visits.
CONCLUSIONS: The hypertension control rate of 44% in US office visits leaves substantial room for improvement. A strong emphasis on improving hypertension management is needed to reduce hypertension-related morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188159     DOI: 10.1038/ajh.2007.35

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  14 in total

1.  Physician characteristics as predictors of blood pressure control in patients enrolled in the hypertension improvement project (HIP).

Authors:  Leonor Corsino; William S Yancy; Gregory P Samsa; Rowena J Dolor; Kathryn I Pollak; Pao-Hwa Lin; Laura P Svetkey
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-04       Impact factor: 3.738

2.  A novel approach to quality improvement in a safety-net practice: concurrent peer review visits.

Authors:  Kevin Fiscella; Ellen Volpe; Paul Winters; Melissa Brown; Amna Idris; Tricia Harren
Journal:  J Natl Med Assoc       Date:  2010-12       Impact factor: 1.798

3.  Receipt of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers among Medicare Beneficiaries with Diabetes and Hypertension.

Authors:  Junling Wang; Satya Surbhi; Julie W Kuhle
Journal:  J Pharm Health Serv Res       Date:  2014-03-01

4.  Antithrombotic Utilization Trends after Noncardioembolic Ischemic Stroke or TIA in the Setting of Large Antithrombotic Trials (2002-2009).

Authors:  Amir S Khan; Saqib Chaudhry; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2015-02

5.  Hypertension-associated hospitalizations and costs in the United States, 1979-2006.

Authors:  Guijing Wang; Jing Fang; Carma Ayala
Journal:  Blood Press       Date:  2013-07-25       Impact factor: 2.835

6.  Synergistic physician and patient behavioral interventions as management strategy for effective population-based hypertension control.

Authors:  Pei-an Betty Shih; Daniel T O'Connor
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

7.  Trends in antihypertensive drug prescription patterns among ambulatory stroke patients in the United States, 2000-2009.

Authors:  Bruce Ovbiagele; Karin Ernstrom; Daniela Markovic; Rema Raman
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-07-17       Impact factor: 2.136

Review 8.  Rationale for triple-combination therapy for management of high blood pressure.

Authors:  Alan H Gradman
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08-20       Impact factor: 3.738

9.  Hypertension prevalence and prescribing trends in older US adults: 1999-2004.

Authors:  Farhan Aslam; Attiya Haque; Joseph V Agostini; Yun Wang; JoAnne M Foody
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-02-01       Impact factor: 3.738

Review 10.  Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy.

Authors:  William J Elliott
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.